Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to ConsiderZacks Investment Research • 02/15/24
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 02/07/24
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?Zacks Investment Research • 02/06/24
Does Adma Biologics (ADMA) Have the Potential to Rally 31.55% as Wall Street Analysts Expect?Zacks Investment Research • 02/05/24
Wall Street Analysts Predict a 27.09% Upside in Adma Biologics (ADMA): Here's What You Should KnowZacks Investment Research • 01/19/24
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a BetZacks Investment Research • 01/17/24
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateGlobeNewsWire • 01/08/24
Are You Looking for a Top Momentum Pick? Why Adma Biologics (ADMA) is a Great ChoiceZacks Investment Research • 01/05/24
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementGlobeNewsWire • 12/18/23
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderGlobeNewsWire • 12/12/23
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MDGlobeNewsWire • 11/16/23